Market Overview:
The global sequencing reagents market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for Next Generation Sequencing (NGS) and Third Generation Sequencing (TGS) technologies, rising prevalence of cancer and other diseases, and growing application areas of sequencing technology. Based on type, the global sequencing reagents market is segmented into Sanger sequencing, NGS, TGS. Sanger sequencing held the largest share in 2017 owing to its low cost and wide availability. However, NGS is expected to grow at a higher rate during the forecast period as it offers high accuracy and speed along with increased flexibility for target enrichment. Based on application area, the global sequencing reagents market is segmented into oncology, reproductive health & diagnostics clinical investigation & research agrigenomics & forensics others). Oncology held the largest share in 2017 due to rising incidence of cancer across all regions worldwide.
Product Definition:
A sequencing reagent is a molecule used in DNA sequencing. These modified nucleotides prevent the polymerase enzyme from extending the sequence further downstream on the template strand when it encounters them. By using different combinations of these four nucleotides, it is possible to read off the sequence of bases in a DNA molecule.
Sanger Sequencing:
Sanger sequencing is a method of DNA sequencing that was developed by the American geneticist, Dr. George Sanger in the late 1950s. The process involves conversion of genomic DNA into labeled nucleic acids, which are then amplified through polymerase chain reaction (PCR). The labeled nucleic acids are resolved with an electrophoresis gel and detected to obtain single-stranded DNA for further analysis.
Next Generation Sequencing:
Next Generation Sequencing (NGS) is a high-throughput sequencing method that enables the production of very large amounts of sequence data with high accuracy and precision. It allows the generation of sufficient data to map 1% of the human genome in a single run, which is 10 times more than current methods allow.
Application Insights:
Oncology accounted for the largest revenue share in 2017 and is expected to continue its dominance over the forecast period. This can be attributed to an increase in cancer prevalence coupled with rising demand for sequencing reagents from pharmaceutical companies and biotechnology firms. A rise in oncology research activities has also fueled market growth. For instance, according to data published by NCBI, there were nearly 1 million unique titles related to cancer genes & pathways in 2015 which represented a significant increase from 2010 when 910,000 unique titles were recorded. Such factors are anticipated to drive segment growth during the forecast period.
Clinical investigation is another lucrative application of these sequencing reagents as they help decipher the molecular mechanisms that lead toward disease progression and identify new therapeutic targets across various diseases such as cardiovascular, diabetes mellitus type 2 & obesity-related disorders among others (cancer was leading).
Regional Analysis:
North America dominated the market in terms of revenue share in 2017. This can be attributed to factors such as local presence of leading players, availability of advanced technologies and high healthcare expenditure. The U.S.-based companies are engaged in strategic initiatives such as mergers and acquisitions to expand their presence across the globe.
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of genetic disorders
- Technological advancements in sequencing platforms and reagents
- Growing number of research studies on genomics and proteomics
- Increasing public and private investments in life sciences research
Scope Of The Report
Report Attributes
Report Details
Report Title
Sequencing Reagents Market Research Report
By Type
Sanger Sequencing, Next Generation Sequencing, Third Generation Sequencing
By Application
Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, Others
By Companies
Thermo Fisher Scientific, Bioline, Takara Bio, ArcherDX, Fluidigm Corporation, Pacific Biosciences of California, F. Hoffmann-La Roche AG, Oxford Nanopore Technologies, Agilent Technologies, Illumina, BGI, Qiagen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Sequencing Reagents Market Report Segments:
The global Sequencing Reagents market is segmented on the basis of:
Types
Sanger Sequencing, Next Generation Sequencing, Third Generation Sequencing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Bioline
- Takara Bio
- ArcherDX
- Fluidigm Corporation
- Pacific Biosciences of California
- F. Hoffmann-La Roche AG
- Oxford Nanopore Technologies
- Agilent Technologies
- Illumina
- BGI
- Qiagen
Highlights of The Sequencing Reagents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sanger Sequencing
- Next Generation Sequencing
- Third Generation Sequencing
- By Application:
- Oncology
- Reproductive Health
- Clinical Investigation
- Agrigenomics & Forensics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sequencing Reagents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sequencing reagents are chemicals that can be used to identify the order of nucleotides in a DNA or RNA molecule.
Some of the major players in the sequencing reagents market are Thermo Fisher Scientific, Bioline, Takara Bio, ArcherDX, Fluidigm Corporation, Pacific Biosciences of California, F. Hoffmann-La Roche AG, Oxford Nanopore Technologies, Agilent Technologies, Illumina, BGI, Qiagen.
The sequencing reagents market is expected to register a CAGR of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Sequencing Reagents Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Sequencing Reagents Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Sequencing Reagents Market - Supply Chain
4.5. Global Sequencing Reagents Market Forecast
4.5.1. Sequencing Reagents Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Sequencing Reagents Market Size (000 Units) and Y-o-Y Growth
4.5.3. Sequencing Reagents Market Absolute $ Opportunity
5. Global Sequencing Reagents Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Sequencing Reagents Market Size and Volume Forecast by Type
5.3.1. Sanger Sequencing
5.3.2. Next Generation Sequencing
5.3.3. Third Generation Sequencing
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Sequencing Reagents Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Sequencing Reagents Market Size and Volume Forecast by Application
6.3.1. Oncology
6.3.2. Reproductive Health
6.3.3. Clinical Investigation
6.3.4. Agrigenomics & Forensics
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Sequencing Reagents Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Sequencing Reagents Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Sequencing Reagents Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Sequencing Reagents Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Sequencing Reagents Demand Share Forecast, 2019-2026
9. North America Sequencing Reagents Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Sequencing Reagents Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Sequencing Reagents Market Size and Volume Forecast by Application
9.4.1. Oncology
9.4.2. Reproductive Health
9.4.3. Clinical Investigation
9.4.4. Agrigenomics & Forensics
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Sequencing Reagents Market Size and Volume Forecast by Type
9.7.1. Sanger Sequencing
9.7.2. Next Generation Sequencing
9.7.3. Third Generation Sequencing
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Sequencing Reagents Demand Share Forecast, 2019-2026
10. Latin America Sequencing Reagents Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Sequencing Reagents Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Sequencing Reagents Market Size and Volume Forecast by Application
10.4.1. Oncology
10.4.2. Reproductive Health
10.4.3. Clinical Investigation
10.4.4. Agrigenomics & Forensics
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Sequencing Reagents Market Size and Volume Forecast by Type
10.7.1. Sanger Sequencing
10.7.2. Next Generation Sequencing
10.7.3. Third Generation Sequencing
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Sequencing Reagents Demand Share Forecast, 2019-2026
11. Europe Sequencing Reagents Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Sequencing Reagents Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Sequencing Reagents Market Size and Volume Forecast by Application
11.4.1. Oncology
11.4.2. Reproductive Health
11.4.3. Clinical Investigation
11.4.4. Agrigenomics & Forensics
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Sequencing Reagents Market Size and Volume Forecast by Type
11.7.1. Sanger Sequencing
11.7.2. Next Generation Sequencing
11.7.3. Third Generation Sequencing
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Sequencing Reagents Demand Share, 2019-2026
12. Asia Pacific Sequencing Reagents Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Sequencing Reagents Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Sequencing Reagents Market Size and Volume Forecast by Application
12.4.1. Oncology
12.4.2. Reproductive Health
12.4.3. Clinical Investigation
12.4.4. Agrigenomics & Forensics
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Sequencing Reagents Market Size and Volume Forecast by Type
12.7.1. Sanger Sequencing
12.7.2. Next Generation Sequencing
12.7.3. Third Generation Sequencing
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Sequencing Reagents Demand Share, 2019-2026
13. Middle East & Africa Sequencing Reagents Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Sequencing Reagents Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Sequencing Reagents Market Size and Volume Forecast by Application
13.4.1. Oncology
13.4.2. Reproductive Health
13.4.3. Clinical Investigation
13.4.4. Agrigenomics & Forensics
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Sequencing Reagents Market Size and Volume Forecast by Type
13.7.1. Sanger Sequencing
13.7.2. Next Generation Sequencing
13.7.3. Third Generation Sequencing
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Sequencing Reagents Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Sequencing Reagents Market: Market Share Analysis
14.2. Sequencing Reagents Distributors and Customers
14.3. Sequencing Reagents Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher Scientific
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bioline
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Takara Bio
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. ArcherDX
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Fluidigm Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pacific Biosciences of California
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. F. Hoffmann-La Roche AG
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Oxford Nanopore Technologies
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Agilent Technologies
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Illumina
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. BGI
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Qiagen
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
